Three phase 3 prostate cancer results from ESMO 2026 cover long-term survival with abiraterone in metastatic disease, Erleada before and after surgery, and an update on Truqap for PTEN-deficient ...
An international phase 3 clinical trial that treated patients with high-risk localized and locally advanced prostate cancer ...
Modern radiotherapy for prostate cancer is as effective as surgery with important advantages in preservation of urinary ...
When James E. Golden was diagnosed with prostate cancer he was suddenly faced with the daunting task of interviewing surgeons ...
A national study of more than 20,000 men with localized prostate cancer found that surgery was linked to higher rates of urinary incontinence and erectile dysfunction, while radiation therapy was ...
A national study of more than 20,000 men with prostate cancer compared long-term outcomes after radiation therapy or surgical removal of the prostate, with follow-up of up to 20 years. Men who ...
The optimal strategy for treating newly diagnosed high-risk prostate cancer remains unclear. More specifically, do these patients benefit more from radical prostatectomy or a radiotherapy-based ...
An international phase 3 clinical trial that treated patients with high-risk localized and locally advanced prostate cancer ...
An international phase 3 clinical trial that treated patients with high-risk localized and locally advanced prostate cancer ...
A STAT investigation found that older women paid up to $30,000 for overseas mitochondrial replacement therapy, despite limited evidence that three-parent IVF improves fertility or addresses ...
Use of NeuroSAFE to guide nerve sparing during robot-assisted radical prostatectomy improved patient-reported erectile function. Researchers have found that the use of the NeuroSAFE technique to guide ...